A look at the potential association between PICOT framing of a research question and the quality of reporting of analgesia RCTs.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4175096)

Published in BMC Anesthesiol on November 19, 2013

Authors

Victoria Borg Debono, Shiyuan Zhang, Chenglin Ye, James Paul, Aman Arya, Lindsay Hurlburt, Yamini Murthy, Lehana Thabane1

Author Affiliations

1: Department of Clinical Epidemiology and Biostatistics, McMaster University, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada. thabanl@mcmaster.ca.

Articles cited by this

The measurement of observer agreement for categorical data. Biometrics (1977) 216.56

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA (1995) 45.41

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet (2001) 31.74

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70

Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ (2001) 20.65

The hazards of scoring the quality of clinical trials for meta-analysis. JAMA (1999) 17.00

What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ (1999) 13.99

Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA (2001) 13.36

The scandal of poor medical research. BMJ (1994) 11.58

Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust (2006) 11.40

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (2008) 11.08

CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med (2010) 9.30

Adjusting for multiple testing--when and how? J Clin Epidemiol (2001) 8.85

Epidemiology and reporting of randomised trials published in PubMed journals. Lancet (2005) 6.55

The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ (2010) 5.58

Probability of adverse events that have not yet occurred: a statistical reminder. BMJ (1995) 5.55

Intention-to-treat analysis: implications for quantitative and qualitative research. Int J Epidemiol (1992) 3.96

Femoral nerve block improves analgesia outcomes after total knee arthroplasty: a meta-analysis of randomized controlled trials. Anesthesiology (2010) 3.42

Scales to assess the quality of randomized controlled trials: a systematic review. Phys Ther (2007) 3.17

Choosing the best research design for each question. BMJ (1998) 3.03

Standards of reporting of randomized controlled trials in general surgery: can we do better? Ann Surg (2006) 3.01

Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology. BMJ (1996) 2.99

Intention to treat--who should use ITT? Br J Cancer (1993) 2.74

The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. Contemp Clin Trials (2005) 2.40

The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study. BMJ (2009) 2.29

Quality of reporting of randomized controlled trials in general endocrinology literature. J Clin Endocrinol Metab (2008) 2.24

A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature. J Urol (2007) 2.16

Has the quality of abstracts for randomised controlled trials improved since the release of Consolidated Standards of Reporting Trial guideline for abstract reporting? A survey of four high-profile anaesthesia journals. Eur J Anaesthesiol (2011) 1.85

Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond. CMAJ (2004) 1.77

The art of quality assessment of RCTs included in systematic reviews. J Clin Epidemiol (2001) 1.69

Association between framing of the research question using the PICOT format and reporting quality of randomized controlled trials. BMC Med Res Methodol (2010) 1.63

Posing the research question: not so simple. Can J Anaesth (2008) 1.57

Quality of reporting of key methodological items of randomized controlled trials in clinical ophthalmic journals. Ophthalmic Epidemiol (2007) 1.57

Quality of randomized controlled trials reporting in the primary treatment of brain tumors. J Clin Oncol (2006) 1.42

Industry funding and the reporting quality of large long-term weight loss trials. Int J Obes (Lond) (2008) 1.32

The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta-epidemiologic study. Arthritis Rheum (2009) 1.30

Adjustment of meta-analyses on the basis of quality scores should be abandoned. J Clin Epidemiol (2006) 1.16

Improvement in the quality of randomized controlled trials among general anesthesiology journals 2000 to 2006: a 6-year follow-up. Anesth Analg (2009) 1.13

Thinking beyond the thomson reuters "impact factor". J Obstet Gynaecol India (2014) 1.02

A systematic review of the quality of publications reporting coronary artery bypass grafting trials. Can J Surg (2007) 0.92

Deciding upon and refining a research question. Palliat Med (2002) 0.86

The research question. Transfusion (2007) 0.83

Asking good clinical research questions and choosing the right study design. Injury (2010) 0.82

The quality of reporting of RCTs used within a postoperative pain management meta-analysis, using the CONSORT statement. BMC Anesthesiol (2012) 0.82

Proposing a good research question: a simple formula for success. Gastrointest Endosc (2005) 0.81

The blind leading the blind: use and misuse of blinding in randomized controlled trials. Contemp Clin Trials (2010) 0.78

The quality of randomized controlled trials in major anesthesiology journals. Anesth Analg (2005) 0.78

Articles by these authors

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42

Femoral nerve block improves analgesia outcomes after total knee arthroplasty: a meta-analysis of randomized controlled trials. Anesthesiology (2010) 3.42

Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma. J Natl Cancer Inst (2004) 2.66

Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients. J Clin Oncol (2005) 2.05

Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol (2008) 1.93

Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex. J Natl Cancer Inst (2013) 1.75

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73

Mobile phone text messages for improving adherence to antiretroviral therapy (ART): an individual patient data meta-analysis of randomised trials. BMJ Open (2013) 1.66

Association between framing of the research question using the PICOT format and reporting quality of randomized controlled trials. BMC Med Res Methodol (2010) 1.63

A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol (2013) 1.63

Posing the research question: not so simple. Can J Anaesth (2008) 1.57

Analgesic efficacy of morphine applied topically to painful ulcers. J Pain Symptom Manage (2003) 1.52

Nitrous oxide and serious morbidity and mortality in the POISE trial. Anesth Analg (2013) 1.50

Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology (2014) 1.47

Sample sizes for clinical trials using sputum eosinophils as a primary outcome. Eur Respir J (2013) 1.42

Key issues and barriers to obstetrical anesthesia care in Ontario community hospitals with fewer than 2,000 deliveries annually. Can J Anaesth (2009) 1.39

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36

Predictors of unanticipated admission following ambulatory surgery: a retrospective case-control study. Can J Anaesth (2013) 1.21

The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status. Curr Colorectal Cancer Rep (2013) 1.12

Prevalence and risk factors of lens opacities in urban and rural Chinese in Beijing. Ophthalmology (2006) 1.10

A systematic scoping review of adherence to reporting guidelines in health care literature. J Multidiscip Healthc (2013) 1.07

Tips for charting the course of a successful health research career. J Multidiscip Healthc (2013) 1.02

Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet (2013) 0.99

Efficacy of vitamin D supplementation in depression in adults: a systematic review. J Clin Endocrinol Metab (2013) 0.93

Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiol Biomarkers Prev (2013) 0.92

What epidural opioid results in the best analgesia outcomes and fewest side effects after surgery?: a meta-analysis of randomized controlled trials. Anesth Analg (2014) 0.90

Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res (2013) 0.89

Trends in Canadian respiratory clinical trials from 2001 to 2011. Can Respir J (2013) 0.87

Continuous infusion of bupivacaine following total knee arthroplasty: a randomized control trial pilot study. J Arthroplasty (2012) 0.87

Motivational interviewing for improving outcomes in youth living with HIV. Cochrane Database Syst Rev (2012) 0.87

The effect of regular physical activity on bone mineral density in post-menopausal women aged 75 and over: a retrospective analysis from the Canadian multicentre osteoporosis study. BMC Musculoskelet Disord (2013) 0.85

Cerebral Oximetry Monitoring to Maintain Normal Cerebral Oxygen Saturation during High-risk Cardiac Surgery: A Randomized Controlled Feasibility Trial. Anesthesiology (2016) 0.84

System integration and its influence on the quality of life of children with complex needs. Int J Pediatr (2010) 0.83

Assessing the effectiveness of 'pulse radiofrequency treatment of dorsal root ganglion' in patients with chronic lumbar radicular pain: study protocol for a randomized control trial. Trials (2012) 0.83

Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunol Res (2014) 0.82

The quality of reporting of RCTs used within a postoperative pain management meta-analysis, using the CONSORT statement. BMC Anesthesiol (2012) 0.82

[Neuronavigation-guided pure endoscopic endonasai transsphenoidal approach for pituitary adenomas]. Zhonghua Yi Xue Za Zhi (2015) 0.82

Intra-abdominal hypertension in the critically ill: interrater reliability of bladder pressure measurement. J Crit Care (2013) 0.80

A survival analysis of GBM patients in the West of Scotland pre- and post-introduction of the Stupp regime. Br J Neurosurg (2013) 0.79

Efficacy of vitamin D supplementation in depression in adults: a systematic review protocol. Syst Rev (2013) 0.79

The validity of EORTC GBM prognostic calculator on survival of GBM patients in the West of Scotland. Br J Neurosurg (2013) 0.78

Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium. PLoS One (2011) 0.78

Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mol Nutr Food Res (2014) 0.77

The impact of a cardiovascular health awareness program (CHAP) on reducing blood pressure: a prospective cohort study. BMC Public Health (2013) 0.77

Safety and efficacy of pulsed imatinib with or without G-CSF versus continuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up. Br J Haematol (2013) 0.76

Exploring attitudes towards a randomised controlled trial of venous access devices - a nested pre-trial qualitative study. J Vasc Access (2015) 0.76

Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort. Anesthesiology (2016) 0.76

Interactions among Ecological Factors That Explain the Psychosocial Quality of Life of Children with Complex Needs. Int J Pediatr (2010) 0.75

A phase I and pharmacokinetic study of capecitabine in combination with radiotherapy in patients with localised inoperable pancreatic cancer. Cancer Chemother Pharmacol (2014) 0.75

Dexamethasone Perioperative Coanalgesia in Lumbar Spine Fusion: A Controlled Cohort Study of Efficacy and Safety. J Spinal Disord Tech (2015) 0.75

Fine motor friend. Top Stroke Rehabil (2011) 0.75

A survey evaluating surgeons' peri-operative usage of acetyl-salicylic acid (ASA) and their willingness to enroll their patients in a perioperative ASA randomized controlled trial. Clin Invest Med (2010) 0.75

A randomized comparison of intraoperative PerfecTemp and forced-air warming during open abdominal surgery. Anesth Analg (2011) 0.75

Are we meeting nutritional targets for critically ill patients? Can J Anaesth (2014) 0.75

Characterization of rainbow trout CHK2 and its potential as a genotoxicity biomarker. Comp Biochem Physiol C Toxicol Pharmacol (2008) 0.75